Navigation Links
BUSM professor authors book on how knowledge about genes and family history can save lives
Date:8/26/2011

lethal genetic disorders and even important treatment," said Milunsky. "By knowing your genes, you may save your life and the lives of those you love."

Milunsky's research accomplishments include leading the research team responsible for first locating the gene for X-linked lymphoproliferative disease and cloning the PAX 3 gene for Waardenburg syndrome. As principal investigator, he also led a team that was the first to demonstrate that 70 percent of spina bifida cases could be avoided by folic acid supplementation taken 3 months prior to pregnancy and 3 months after conception.

Milunsky joined the Boston University community in 1982 when he was named Founding Director of the Center for Human Genetics and appointed Professor of Pediatrics and Obstetrics and Gynecology, both at BUSM. He became a Professor of Pathology in 1985, and in 1991 became the first Endowed Chair in Human Genetics at BUSM, which will be named for him upon his retirement. He has been honored by election as a Fellow of the Royal College of Physicians of England and as a member of the Society for Pediatric Research and the American Pediatrics Society. He is also a Founding Fellow of the American College of Medical Genetics.

In addition to his academic and research successes, Milunsky is the author or co-author of more than 400 scientific communications and author, editor or co-editor of 24 books.

Your Genes, Your Health: A Critical Family Guide That Could Save Your Life, was published by Oxford University Press and is available now to the public.


'/>"/>

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. BUSM professor awarded $13.3 million to study potential treatments to prevent STDs
2. FASEB MARC program announces the travel award recipients for the 2011 Leadership Development and Grant Writing Seminar for graduate students, postdoctoral fellows and new assistant professors
3. MSU professor launches new field of water research, nets $2.2 million NSF grant
4. Trauma drama: K-State professor researches drama queen of immune system
5. Acclaimed chemistry professor wins 2 major awards
6. University of Houston professor co-authors PNAS paper on how bacteria move
7. BUSM professor selected as American Heart Association Distinguished Scientist
8. CWRU law professor eyes prize-based incentives to generate climate innovation
9. Sugar-based chemicals book chapter by NJIT professor takes ACS kudos
10. University of Texas at Austin professor receives Donald L. Katz Award
11. CSHL professor Rob Martienssen receives prestigious appointment as HHMI-GBMF investigator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... + Lomb, the global eye health company, announced today that ... unowned shares of Technolas ™ Perfect Vision GmbH (TPV), ... was established in 2009 through a joint venture between Bausch ... sell advanced refractive and cataract technologies. The deal is expected ...
... -- Four innovating life science fields to keep an ... and tissue culture. Thanks to an aging population and ... these markets are on the rise. (Photo: ... (GII) presents four innovative life science market research reports ...
... . , Methane is formed under the absence ... the sea floor. It is a much more powerful greenhouse ... this gas is inactivated before it reaches the atmosphere and ... have now proven that these microorganisms are quite picky about ...
Cached Biology News:Bausch + Lomb to Acquire Technolas Perfect Vision GmbH 2Bausch + Lomb to Acquire Technolas Perfect Vision GmbH 3Global Market for Blood Banking and Blood Products Projected to reach $43 billion by 2018; Spectrometers and Fluorometers to Reach $18.4 bn; Anticoagulants to Reach $12.9 bn; Cell and Tissue Culture Supplies to Reach $5.6 bn 2Global Market for Blood Banking and Blood Products Projected to reach $43 billion by 2018; Spectrometers and Fluorometers to Reach $18.4 bn; Anticoagulants to Reach $12.9 bn; Cell and Tissue Culture Supplies to Reach $5.6 bn 3Global Market for Blood Banking and Blood Products Projected to reach $43 billion by 2018; Spectrometers and Fluorometers to Reach $18.4 bn; Anticoagulants to Reach $12.9 bn; Cell and Tissue Culture Supplies to Reach $5.6 bn 4Strange diet for methane consuming microorganisms 2
(Date:12/24/2014)... According to Ross Selinger, President of ... Global, the national office market continues to be strong, driven ... evidenced by the third quarter’s surprising 3.9% GDP, unemployment decreasing ... costs have held inflation down and the Fed is keeping ... market remaining soft. , This solid economic news is having ...
(Date:12/24/2014)... 23, 2014 Pipette.com announces their ... followers can submit their #HolidayInTheLab pictures for a chance ... mates. , For those struggling to think of a ... Holiday in the Lab Contest provides the ideal holiday ... to send pictures of their chemistree, holiday sweaters, ...
(Date:12/24/2014)... 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR ... December 22, 2014, thereby completing the U.S. HSR ... acquisition of the Company by Merck KGaA, Darmstadt, ... another condition to closing the transaction, which remains ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... iKnowMed™, the US Oncology ... vendors selected to participate in the fourth American Society of ... June 5-7 at the 2010 ASCO Annual Meeting ... company uniting the nation,s largest network of community-based oncologists, will ...
... , MENLO PARK, Calif. and KANNAPOLIS, N.C. ... Inc. (ITI) and the David H. Murdock Research Institute (DHMRI) ... Path Research in Immunology (CCPRI) at The David H. Murdock ... Kannapolis, NC . Driven by a mission to accelerate the ...
... , , , ... Data Shows ORMD-0801 Resulted in Glucose and C-Peptide Reduction , ... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a,developer ... the safety and pharmacodynamics,of five oral insulin formulations in healthy subjects," authored by Dr. ...
Cached Biology Technology:US Oncology(R) to Demonstrate iKnowMed(TM) in the EHR Lab at the 2010 ASCO Annual Meeting 2US Oncology(R) to Demonstrate iKnowMed(TM) in the EHR Lab at the 2010 ASCO Annual Meeting 3US Oncology(R) to Demonstrate iKnowMed(TM) in the EHR Lab at the 2010 ASCO Annual Meeting 4US Oncology(R) to Demonstrate iKnowMed(TM) in the EHR Lab at the 2010 ASCO Annual Meeting 5The Immune Tolerance Institute and David H. Murdock Research Institute Announce a Partnership Establishing a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development 2The Immune Tolerance Institute and David H. Murdock Research Institute Announce a Partnership Establishing a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development 3Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism 2Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism 3
Request Info...
... service provides the premium quality siRNAs you ... siRNAs can be readily ordered online by ... or by providing the sense and antisense ... Validated and Silencer Pre-designed siRNAs, which are ...
... Ambion's custom siRNA service provides the ... gene silencing research. Custom siRNAs can be ... 19-21 base target sequence, or by providing ... check out Ambion's Silencer Validated and Silencer ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Biology Products: